brazzo / iStockphoto.com

13 December 2018Biotechnology

Conference preview: 11th Pharma & Biotech Patent Litigation

We are entering a new era for European patent litigation which will have resounding effects on the life sciences industry.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Life sciences leaders recognised at LSPN Awards USA 2025

LSPN: Counsel grapple with AI’s impact on training and critical thinking

Taylor Wessing expands in Europe with Paris team

ResMed voids sleep apnoea tech patent at PTAB

Novartis settles with licensee of blood cancer therapy day before trial

UPC orders 17-country ban on EOFlow's pumps in Insulet feud

Biotech and healthcare expert returns to Latham & Watkins

AstraZeneca to appeal invalidated diabetes patent in generics dispute